Tofflon Science and Technology Group Co., Ltd. (SHE:300171)
13.89
+1.04 (8.09%)
Sep 14, 2026, 3:04 PM CST
SHE:300171 Revenue
Tofflon Science and Technology Group had revenue of 1.43B CNY in the quarter ending June 30, 2026, with 10.45% growth. This brings the company's revenue in the last twelve months to 5.34B, up 3.71% year-over-year. In the year 2025, Tofflon Science and Technology Group had annual revenue of 5.23B with 4.45% growth.
Revenue (ttm)
5.34B
Revenue Growth
+3.71%
P/S Ratio
1.83
Revenue / Employee
974.44K
Employees
5,479
Market Cap
9.78B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.23B | 222.78M | 4.45% |
| Dec 31, 2024 | 5.01B | -631.55M | -11.19% |
| Dec 31, 2023 | 5.64B | 172.27M | 3.15% |
| Jan 1, 2023 | 5.47B | 1.28B | 30.46% |
| Jan 1, 2022 | 4.19B | 1.48B | 54.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Blue Sail Medical | 6.61B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.35B |
| Shenyang Xingqi Pharmaceutical | 2.71B |
| Zhonghong Pulin Medical Products | 2.61B |
| Autek China | 1.86B |
| Eyebright Medical Technology (Beijing) | 1.63B |
| Sansure Biotech | 1.61B |
| Aidite (Qinhuangdao) Technology | 1.13B |